In vitro synergistic antimicrobial activity of a combination of meropenem, colistin, tigecycline, rifampin, and ceftolozane/tazobactam against carbapenem-resistant …
YG Ju, HJ Lee, HS Yim, MG Lee, JW Sohn, YK Yoon - Scientific reports, 2022 - nature.com
We investigated the in vitro activity of various antimicrobial combinations against
carbapenem-resistant Acinetobacter baumannii (CRAB) isolates. The in vitro activity of six …
carbapenem-resistant Acinetobacter baumannii (CRAB) isolates. The in vitro activity of six …
Synergistic killing by meropenem and colistin combination of carbapenem-resistant Acinetobacter baumannii isolates from Chinese patients in an in vitro …
Carbapenem-resistant Acinetobacter baumannii (CRAB) is an important clinical threat.
Combination therapy that exerts a synergistic effect has become a potential solution to …
Combination therapy that exerts a synergistic effect has become a potential solution to …
[HTML][HTML] In vitro Evaluation of the Colistin-Carbapenem Combination in Clinical Isolates of A. baumannii Using the Checkerboard, Etest, and Time-Kill Curve …
MAH Soudeiha, EA Dahdouh, E Azar… - Frontiers in cellular …, 2017 - frontiersin.org
The worldwide increase in the emergence of carbapenem resistant Acinetobacter
baumannii (CRAB) calls for the investigation into alternative approaches for treatment. This …
baumannii (CRAB) calls for the investigation into alternative approaches for treatment. This …
Comparative in vitro antimicrobial susceptibilities and synergistic activities of antimicrobial combinations against carbapenem-resistant Acinetobacter species …
WH Sheng, JT Wang, SY Li, YC Lin, A Cheng… - … and infectious disease, 2011 - Elsevier
Therapeutic options for the treatment of infections caused by carbapenem-resistant
Acinetobacter baumannii (CRAB) are limited. In vitro activity of amikacin, ciprofloxacin …
Acinetobacter baumannii (CRAB) are limited. In vitro activity of amikacin, ciprofloxacin …
The efficacy of colistin monotherapy versus combination therapy with other antimicrobials against carbapenem-resistant Acinetobacter baumannii ST2 isolates
J Li, Y Fu, J Zhang, Y Zhao, X Fan, L Yu… - Journal of …, 2020 - Taylor & Francis
This study aimed to investigate the efficacy of colistin both alone and in combination with
either meropenem or levofloxacin against CRAB clinical isolates. The OXA carbapenemase …
either meropenem or levofloxacin against CRAB clinical isolates. The OXA carbapenemase …
Combatting Planktonic and Biofilm Populations of Carbapenem-Resistant Acinetobacter baumannii with Polymyxin-Based Combinations
M Wences, ER Wolf, C Li, N Singh, N Bah, X Tan… - Antibiotics, 2022 - mdpi.com
Carbapenem-resistant Acinetobacter baumannii (CRAB) can cause serious infections that
are associated with high mortality rates. During the course of an infection, many CRAB …
are associated with high mortality rates. During the course of an infection, many CRAB …
In Vitro Activity of Minocycline Alone and in Combination with Cefoperazone-Sulbactam Against Carbapenem-Resistant Acinetobacter baumannii
G Pei, Y Mao, Y Sun - Microbial Drug Resistance, 2012 - liebertpub.com
The aim of this study was to investigate the in vitro activity of minocycline combined with
cefoperazone-sulbactam against carbapenem-resistant Acinetobacter baumannii (CRAB). A …
cefoperazone-sulbactam against carbapenem-resistant Acinetobacter baumannii (CRAB). A …
In vitro activities of carbapenem/sulbactam combination, colistin, colistin/rifampicin combination and tigecycline against carbapenem-resistant Acinetobacter …
JY Song, SY Kee, IS Hwang, YB Seo… - Journal of …, 2007 - academic.oup.com
Objectives To determine the in vitro activities and interactions of imipenem, colistin and
tigecycline with old antibacterial agents against carbapenem-resistant Acinetobacter …
tigecycline with old antibacterial agents against carbapenem-resistant Acinetobacter …
Synergistic Antibacterial Activity of Combined Antimicrobials and the Clinical Outcome of Patients With Carbapenemase-Producing Acinetobacter baumannii Infection
J Qu, R Yu, Q Wang, C Feng, X Lv - Frontiers in Microbiology, 2020 - frontiersin.org
This study aimed to explore the activity of combined antimicrobials in vitro, and the
relationship among resistance mechanisms, antimicrobial regimens, and the clinical …
relationship among resistance mechanisms, antimicrobial regimens, and the clinical …
Polymyxin B Combined with Minocycline: A Potentially Effective Combination against blaOXA-23-harboring CRAB in In Vitro PK/PD Model
X Qu, X Bian, Y Chen, J Hu, X Huang, Y Wang, Y Fan… - Molecules, 2022 - mdpi.com
Polymyxin-based combination therapy is commonly used to treat carbapenem-resistant
Acinetobacter baumannii (CRAB) infections. In the present study, the bactericidal effect of …
Acinetobacter baumannii (CRAB) infections. In the present study, the bactericidal effect of …